Ann Rheum Dis
The US Food and Drug Administration (FDA) has approved Wegovy to: Reduce body weight and support long-term weight loss in people with obesity or with overweight and a weight-related health condition, such as type 2 diabetes or sleep apnea Reduce the risk of experiencing a major cardiovascular event , such as heart attack, stroke, or death, in people with heart disease and obesity or overweight Typically, healthcare providers prescribe a starting dose of 0.25 mg weekly
Losing weight is considered one of the best ways to help reduce the symptoms of osteoarthritis, especially in the knee joints
I have had incredible success and am in the healthiest state of my adult life
Mariappan P, Ballantyne Z, NDow JM, Alhasso AA
The states they currently do not ship to include AR, IN, MN, SC and TX (Texas requires doctors to have TX license)